Study Effect of Fibrinogen on Patients with Cardiovascular Disease

Authors

  • Zahraa Salim Hamash
  • Hasan Hashim Ali
  • Hanan Abbas Obaid

DOI:

https://doi.org/10.51699/ijhsms.v2i10.2720

Abstract

Cardio vascular disease has become a great problem throughout the world. It is connected to increase morbidity and mobility and decrease quality of life in patients compared to the general population. many cases of disease has been described in cardiovascular disease. The study conducted on too Iraqi patient with chronic atherosclerosis at age rang (29-70years) in Baquba teaching hospital in (center care unit) during the period from 25 September 2020to may 2021. The patients divided in (55 mans and 45 patients) the total patient divided in tow groups according the treatment (30) of total patient under go to treatment for two to three days after atherosclerosis and 70 patient in same day of diagnosis of atherosclerosis. Fibrinogen value increase and we can use this as biomarkers with Atherosclerosis.

Downloads

Download data is not yet available.

References

Heller RF, Chinn S, Tunstall-Pedoe HD, Rose G. How well can we predict coronary heart disease? BMJ 1984; 288: 41D--Il.

Ernst E. Plasma fibrinogen - an independent cardiovascular risk factor. J Int Med 1990; 227: 365-72.

Dang CV, Bell WR. The normal and morbid biology offibrinogen. Am J Med 1989; 87: 567-76.

Rabbani LE, Loscalzo J. Recent observations on the role of hemostatic determinants in the development of atherothrombotic plaque. Atherocslerosis 1994; lOS: 1-7

Jun Wang, Lu Jia, Xing Li, Siyu Jin, Xiaomei Li , Fen Liu, Chunfang Shan, Yu Zhang, and Yining Yang " New Insights into the Association between Fibrinogen and Coronary Atherosclerotic Plaque Vulnerability: An Intravascular Optical Coherence Tomography Study" Cardiovascular therapeutics , pp. 12 (2019).

Ping Jiang, Zhan Gao, Wei Zhao, Ying Song, Xiao-Fang Tang, Jing-Jing Xu, Huan-Huan Wang, Lin Jiang, Jue Chen, Shu-Bin Qiao, Yue-Jin Yang, Run-Lin Gao, Bo Xu, and Jin-Qing Yuan " Relationship between fibrinogen levels and cardiovascular events in patients receiving percutaneous coronary intervention: a large single-center study" Chinese Medical journal , 132(8): 914–921(2019).

Downloads

Published

2023-10-27

How to Cite

Hamash, Z. S. ., Ali, H. H. ., & Obaid, H. A. . (2023). Study Effect of Fibrinogen on Patients with Cardiovascular Disease. INTERNATIONAL JOURNAL OF HEALTH SYSTEMS AND MEDICAL SCIENCES, 2(10), 129–131. https://doi.org/10.51699/ijhsms.v2i10.2720

Issue

Section

Articles